Pokmon Card Boom Nostalgia Speculation and HighProfile Collectors Drive MultiMillion Dollar Market US Retail Sales Stagnate in December Missing Growth Expectations Trump Pressures Bank of America JPMorgan on Alleged Conservative Debanking Obsession and The Mandalorian Grogu Deliver Blockbuster Box Office Results Consumer Credit Growth Surges in December Signaling Robust Consumer Spending Shell Receives Upgrade to Buy Following ARC Resources Deal Completion Haymaker Acquisition Corp 4 HYAC Q4 2025 Earnings Significant EPS Surprise Driven by Trust Interest Income CDP Q1 2026 Earnings EPS Slightly Beats Estimates on Stable Portfolio Performance CLSK Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Edge Higher Newton Golf Company Inc NWTG Q1 2026 Earnings EPS Misses Estimates as Stock Declines Over 8 BGSI Q1 2026 Earnings Modest EPS Miss Amid Stable Operations LECO Q1 2026 Earnings Modest EPS Beat Amidst Steady Operational Performance MEVOW Holds Steady at 039 M Evo Global Acquisition Corp II Warrants Show Minimal Movement Aris Mining ARIS Faces Resistance at 178 Support Tested at 161 Strategic Education Inc STRA Hovers Near Key Support Amid Modest Decline Aytu BioPharma Rallies as Shares Test Key Resistance Levels USANA Health Sciences USNA Climbs 097 as Stock Approaches Key Resistance Zone Market Update Key Movers Across Telecom Retail and Social Media Sectors MAGN Q1 2026 Earnings Wide EPS Miss Signals Operational Pressure Arbe Robotics Warrants ARBEW Surge 40 Key Levels and Outlook WWW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Brand Strength Catalyst Bancorp Inc CLST Q3 2025 Earnings Modest Profitability Amid Quiet Quarter TTM Technologies Q1 2026 Earnings EPS Surprises to the Upside Amid Strong Operating Execution Reliance Inc RS Q1 2026 Earnings Strong EPS Beat Drives Stock Higher T Stamp IDAI Q1 2026 Earnings EPS Miss Widens as Revenue Details Remain Undisclosed Knowles Corporation KN Q1 2026 Earnings EPS Beat Drives Stock Higher SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment